Do new concepts for deriving permissible limits for analytical imprecision and bias have any advantages over existing consensus?

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 4, 2011, Pages 637-640

  Petersen, Per Hyltoft ^a,d   Sandberg, Sverre ^a,b   Fraser, Callum G ^c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c Scottish Bowel Screening Centre Laboratory   (United Kingdom)

^d NONE   (Denmark)

Author keywords

analytical goals; analytical quality specifications; biological variation; clinical situations; hierarchy of specifications; medical opinions

Indexed keywords

ACCURACY; ARTICLE; DECISION MAKING; EVIDENCE BASED MEDICINE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; INTERNATIONAL NORMALIZED RATIO; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

BIAS (EPIDEMIOLOGY); CLINICAL LABORATORY TECHNIQUES; CONSENSUS; DIAGNOSTIC ERRORS; HUMANS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 79954529472     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.117     Document Type: Article

References (28)

1. Haeckel R, Wosniok W. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art. Clin Chem Lab Med 2011;49:623-35.
2. Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press, 2001.
3. Westgard JO. Basic QC practices, 3rd ed. Madison, WI: West-gard QC, 2010.
4. Fraser CG, Scott MG. Analytical performance requirements for point-of-care testing: glucose as an example. In: Price CP, StJohn A, Kricka LJ, editors. Point-of-care testing: needs, opportunity, and innovation, 3rd ed. Washington, DC: AACC Press, 2010:145-56.
5. Fraser CG. Desirable performance standards for clinical chem-istry tests. Adv Clin Chem 1983;23:299-339.
6. Fraser CG, Hyltoft Petersen P. Analytical performance charac-teristics should be judged against objective quality specifica-tions. Clin Chem 1999;45:321-3. (Pubitemid 29114165)
7. Hyltoft Petersen P, Fraser CG, Kallner A, Kenny D, editors. Strategies to set global analytical quality specifications in lab-oratory medicine. Scand J Clin Lab Invest 1999;59:475-585.
8. Skeie S, Perich C, Ricos C, Araczki A, Horvath AR, Oosterhuis WP, et al. Postanalytical external quality assessment of blood glucose and hemoglobin A1c: an international survey. Clin Chem 2005;51:1145-53. (Pubitemid 43079391)
9. Sciacovelli L, Secchiero S, Zardo L, Zaninotto M, Plebani M. External quality assessment: an effective tool for Clinical Gov-ernance in laboratory medicine. Clin Chem Lab Med 2006; 44:740-9. (Pubitemid 43832870)
10. Dhatt GS, Agarwal MM, Bishawi B, Gill J. Implementing the Stockholm Conference hierarchy of objective quality criteria in a routine laboratory Clin Chem Lab Med 2007;45:549-52. (Pubitemid 46632225)
11. Plebani M. Quality specifications: self pleasure for clinicallab- oratories or added value for patient management? Clin Chem Lab Med 2007;45:462-6. (Pubitemid 46632215)
12. Westgard JO. Managing quality vs. measuring uncertainty in the medical laboratory Clin Chem Lab Med 2010;48:31-40.
13. Burnett D, Ceriotti F, Cooper G, Parvin C, Plebani M, Westgard J. Collective opinion paper on findings of the 2009 convocation of experts on quality control. Clin Chem Lab Med 2010;48: 41-52.
14. Hyltoft Petersen P, Fraser CG Strategies to set global analytical quality specifications in laboratory medicine: 10 years on from the Stockholm consensus conference. Accred Qual Assur 2010;15:323-30.
15. Ricós C, García-Lario J-V, Alvarez V, Cava F, Domenech M, Hernández A, et al. Biological variation database, and quality specifications for imprecision, bias and total error (desirable and minimum). The 2010 update. wwwwestgard.com/bio-database1.htm.
16. Ricos C, Iglesias N, Garcia-Lario J-V, Simón M, Cava F, Her-nández A, et al. Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 2007:44:343-52. (Pubitemid 351724670)
17. Fraser CG, Hyltoft Petersen P, Libeer JC, Ricos C Proposals for setting generally applicable quality goals solely based on biology Ann Clin Biochem 1997;34:8-12. (Pubitemid 27067864)
18. Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ, et al. Current issues in measurement and report-ing of urinary albumin excretion. Clin Chem 2009:55;24-38.
19. Solberg HE. Approved Recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1987;25:645-56.
20. Gowans EM, Hyltoft Petersen P, Blaabjerg O, Hørder M. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest 1988;48:757-64. (Pubitemid 19005823)
21. Fraser CG, Hyltoft Petersen P, Ricos C, Haeckel R. Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry Eur J Clin Chem Clin Biochem 1992;30:311-7.
22. Stöckl D, Baadenhuijsen H, Fraser CG, Libeer J-C, Hyltoft Petersen P, Ricós C Desirable routine analytical goals for quan-tities assayed in serum. Discussion paper from the members of the external quality assessment (EQA) working group A on analytical goals in laboratory medicine. Eur J Clin Chem Clin Biochem 1995;33:157-69
23. Klee GG Tolerance limits for short-term analytical bias and analytical imprecision derived from clinical assay specificity Clin Chem 1993;39:1514-8. (Pubitemid 23215342)
24. 1c derived using different strategies. Ann Clin Biochem 1991;26:272-8.
25. Richtlinie der Bundesärztekammer zur Qualitätssicherung labo-ratoriumsmedizinischer Untersuchungen. Dt Aerzteblatt 2008; 105:C301-13.
26. Sølvik UØ, Hyltoft Petersen P, Monsen G, Stavelin AV, Sand-berg S. Discrepancies in International Normalized Ratio (INR) results between instruments; a model to split the variation into subcomponents. Clin Chem 2010;56:1618-26.
27. Shermock KM, Connor JT, Lavallee DC, Streiffs MB. Clinical decision-making as the basis for assessing agreement between measures of the international normalized ratio. Thromb Hae-most 2008;7:87-93.
28. Klee GG Establishment of outcome-related analytic perform-ance goals. Clin Chem 2010;56:714-22.